Evidence map›Paper›PMID 34364949›Full record

ArticleThe Journal of infection2022

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.

Jeromie Wesley Vivian Thangaraj, Pragya Yadav, Cp Girish Kumar, Anita Shete, Dimpal A Nyayanit, D Sudha Rani, Abhinendra Kumar, Muthusamy Santhosh Kumar, R Sabarinathan, V Saravana Kumar and 2 more

Abstract readLetterComment
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Delta variant SARS-CoV-2 infections in pediatric cases during the second wave in India.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2022
    Article
  12. Review
  13. Article
  14. Spike protein of SARS-CoV-2 variants: a brief review and practical implications.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Review
  15. Article
  16. Why are people antiscience, and what can we do about it?Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jeromie Wesley Vivian ThangarajNational Institute of Epidemiology, R127, TNHB, Ayapakkam, Ambattur, Chennai 600077, India.
Pragya YadavICMR National Institute of Virology, Pune, Maharashtra.
Cp Girish KumarICMR National Institute of Epidemiology, Chennai, Tamil Nadu.
Anita SheteICMR National Institute of Virology, Pune, Maharashtra.
Dimpal A NyayanitICMR National Institute of Virology, Pune, Maharashtra.
D Sudha RaniICMR National Institute of Epidemiology, Chennai, Tamil Nadu.
Abhinendra KumarICMR National Institute of Virology, Pune, Maharashtra.
Muthusamy Santhosh KumarICMR National Institute of Epidemiology, Chennai, Tamil Nadu.
R SabarinathanICMR National Institute of Epidemiology, Chennai, Tamil Nadu.
V Saravana KumarICMR National Institute of Epidemiology, Chennai, Tamil Nadu.
M JagadeesanGreater Chennai Corporation, Tamil Nadu, India.
Manoj MurhekarNational Institute of Epidemiology, R127, TNHB, Ayapakkam, Ambattur, Chennai 600077, India. Electronic address: mmurhekar@nieicmr.org.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansIndiaSARS-CoV-2COVID-19COVID-19 breakthrough infectionsIndiaSARS-CoV-2VaccinesVariant of Concern

Identifiers

PMID34364949
PMCPMC8343391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.